InvestSMART

Cochlear Limited (ASX:COH)

ALERT: Price-sensitive ASX Announcement for COH
Current share price for COH : $136.100 -152.27 (-52.80%)+
Announcement
Release
23 Oct 2025 8:22AM
Price at Release
$288.370
Full Release
download
Summary
Cochlear Limited, a leader in implantable hearing solutions, emphasized its commitment to innovation, strong financial management, and sustainability during its 2025 Annual General Meeting. The company reported a 3% increase in sales revenue to $2.4 billion for FY25, driven by growth in cochlear and acoustic implants, despite a decline in services revenue. Underlying net profit rose by 1% to $392 million, with dividends increasing by 5%. Looking forward, Cochlear projects an 11-17% increase in net profit for FY26. Key achievements include the launch of the Cochlear Nucleus Nexa System, the world’s first smart cochlear implant system, and significant investment in R&D. The company is deeply committed to environmental responsibility, having reduced emissions significantly and achieved near-complete renewable energy use at its manufacturing sites. Leadership development and board renewal remain priorities, with new board members adding valuable expertise.
Key Points
  • Cochlear Limited's 2025 AGM addressed its growth and innovation focus.
  • FY25 sales revenue increased to $2.4 billion, with net profit at $392 million.
  • The company launched the Cochlear Nucleus Nexa System, a smart cochlear implant.
  • Significant R&D investment of over $290 million, representing 12% of revenue.
  • Commitment to sustainability with a reduction in emissions and renewable energy use.
  • Projected FY26 net profit increase of 11-17% over FY25.
  • Emphasis on leadership development and board renewal.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.